Study of impact of EU label changes for fluoroquinolone containing medicinal products for systemic and inhalation use - post-referral prescribing trends
Study of impact of EU label changes for fluoroquinolone containing medicinal products for systemic and inhalation use - post-referral prescribing trends
Due to a new release taking place on 2nd July between 08:00-09:00 CET, users should refrain from submitting or editing records during this time as any changes might get lost